ArticleCancer research and treatment2019
Patient and Care Delays of Breast Cancer in China.
Article in Cancer research and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Duration of the patient interval in breast cancer and factors associated with longer delays in low-and middle-income countries: A systematic review with meta-analysis.Psycho-oncology · 2023Pooled it
- A Multidisciplinary Breast Cancer Clinic Improves Time to Treatment at an Urban, Safety Net Hospital.Annals of surgical oncology · 2026Article
- Delay in seeking medical care among breast cancer patients with malignant fungating wounds and their caregivers: a qualitative dyadic study.Frontiers in public health · 2026Article
- The Impact of the COVID-19 Pandemic on Patients with Breast Cancer, Diagnostic Delays and Disease Progression: A Retrospective Study.Iranian journal of medical sciences · 2026Article
- Factors Influencing Healthcare-Seeking Delay Among Chinese Residents: A Cross-Sectional Study.Patient preference and adherence · 2026Article
- The experience of musculoskeletal symptoms among patients with breast cancer during aromatase inhibitor therapy: A qualitative study.Asia-Pacific journal of oncology nursing · 2025Article
- Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China.Journal of surgical oncology · 2025Article
- Delays in follow-up among women with abnormal results: a retrospective study based on population-based breast cancer screening programme in China.BMC public health · 2025Article
- The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism.Journal of cellular and molecular medicine · 2025Article
- Systems delay in women with breast cancer - A sequential explanatory mixed-methods study from central rural India.Journal of family medicine and primary care · 2024Article
- Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain.Therapeutic advances in medical oncology · 2024Article
- Review
- The Firmicutes/Bacteroidetes Ratio as a Risk Factor of Breast Cancer.Journal of clinical medicine · 2023Article
- Factors Associated with Diagnostic Delays among Tunisian Breast Cancer Patients.Asian Pacific journal of cancer prevention : APJCP · 2023Article
- Clinical application of ultrasound-guided thoracic nerve block in the operation of benign breast tumors.American journal of translational research · 2023Article
- Predictors of Medical Care Delay or Avoidance Among Chinese Adults During the COVID-19 Pandemic.Patient preference and adherence · 2023Article
- Delay in Diagnosis and Treatment of Primary Bone Tumors during COVID-19 Pandemic in Poland.Cancers · 2022Article
- Delay in Seeking Medical Attention and Diagnosis in Chinese Melanoma Patients: A Cross-Sectional Study.International journal of environmental research and public health · 2022Article
- Research on body image cognition, social support and illness perception in breast cancer patients with different surgical methods.Frontiers in psychology · 2022Article
- LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.American journal of translational research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThis study differentiates patient and care delays of breast cancer and explores the related factors as well as the associations with the prognosis in Guangzhou, a southern city of China.
methodsA cohort of female incident breast cancer patients (n=1,551) was recruited from October 2008 to March 2012 and followed up until January 1, 2016 (n=1,374) in the affiliated hospitals of Sun Yat-sen University. The factors associated with patient and care delays were analyzed with multivariable logistic models. Cox proportional hazards regression models were constructed to estimate the impacts of the delays on the prognosis.
resultsThere were 40.4% patient delay (≥3 months) and 15.5% care delay (≥1 month). The patient delay, but not the care delay, was significantly related to the clinical stage and consequently worsened the prognosis of breast cancer (hazard ratio, 1.45; 95% confidence interval, 1.09 to 1.91 for progression-free survival). The factors related to an increased patient delay included premenopausal status, history of benign breast disease, and less physical examination.
conclusionPatient delay was the main type of delay in Guangzhou and resulted in higher clinical stage and poor prognosis of breast cancer. Screening for breast cancer among premenopausal women may be an effective way to reduce this delay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.